[Form 4] BED BATH & BEYOND, INC. Insider Trading Activity

Rhea-AI Filing Summary

Bed Bath & Beyond (BBBY)116,686 restricted stock units (RSUs) of Bed Bath & Beyond common stock at a price of $0 per unit.

Each RSU represents a contingent right to receive one share of common stock. The award vests in three equal installments at the close of business on November 3, 2026, November 3, 2027 and November 3, 2028, with vested shares to be delivered to the executive promptly after each vesting date. Following this grant, the executive holds 116,686 derivative securities directly.

11/18/2025 - 04:14 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lockton Rick

(Last) (First) (Middle)

433 ASCENSION WAY

SUITE 300

(Street)

MURRAY UT 84123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BED BATH & BEYOND, INC. [ BBBY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	11/14/2025		A		116,686		(1)	(1)	Common Stock	116,686	$0	116,686	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest in three equal installments at the close of business on November 3, 2026, November 3, 2027 and November 3, 2028. Vested shares will be delivered to the reporting person promptly after the restricted stock units vest.

Remarks:

Executive Vice President, Chief Digital, Product, and Technology Officer

	/s/ Christina Wheeler, Attorney-in-Fact	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Bed Bath & Beyond (BBBY) disclose in this Form 4 filing?

The filing reports that a company officer received 116,686 restricted stock units (RSUs) of Bed Bath & Beyond common stock on 11/14/2025.

Who received the equity award reported by BBBY and in what role?

The equity award went to an officer who serves as Executive Vice President, Chief Digital, Product, and Technology Officer of Bed Bath & Beyond.

How many Bed Bath & Beyond RSUs were granted and at what price?

The officer was granted 116,686 RSUs with an exercise or conversion price of $0 per restricted stock unit.

What is the vesting schedule for the 116,686 BBBY restricted stock units?

The RSUs vest in three equal installments at the close of business on November 3, 2026, November 3, 2027 and November 3, 2028, with shares delivered promptly after vesting.

What does each Bed Bath & Beyond restricted stock unit represent?

Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond common stock upon vesting.

How many derivative securities does the BBBY officer hold after this transaction?

After the reported transaction, the officer beneficially owns 116,686 derivative securities, held directly.